Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 3,331 | 3,702 | 3,489 | 3,951 | 2,847 |
| Operating Income | -3,331 | -3,702 | -3,489 | -3,951 | -2,847 |
| Other Income | -46 | 343 | 52 | 17 | 13 |
| Pre-tax Income | -3,377 | -3,359 | -3,437 | -3,934 | -2,834 |
| Net Income Continuous | -3,377 | -3,359 | -3,437 | -3,934 | -2,834 |
| Net Income | $-3,377 | $-3,359 | $-3,437 | $-3,934 | $-2,834 |
| EPS Basic Total Ops | -1.29 | 5.22 | -1.75 | -6.25 | -7.58 |
| EPS Basic Continuous Ops | -1.29 | 5.34 | -1.81 | -6.32 | -7.58 |
| EPS Diluted Total Ops | -1.29 | 5.22 | -1.75 | -6.25 | -7.58 |
| EPS Diluted Continuous Ops | -1.29 | 5.34 | -1.81 | -6.32 | -7.58 |
| EPS Diluted Before Non-Recurring Items | -1.29 | N/A | -1.75 | -6.25 | -7.50 |
| EBITDA(a) | $-3,331 | $-3,702 | $-3,489 | $-3,951 | $-2,847 |